I think the shorts will be in control of this one for a while and will look to close out their positions at the next CR. I expect cash burn to increase significantly as CLARIFY and AMPLIFY hit their straps this year.
When they raised $121m in March 2024, they said they were funded to early 2026. This will be before the results of either of those trials will be available. I don’t think the market will attribute much value to the co-PSMA trial even if the results are spectacular as CLARIFY and AMPLIFY are the only ones that matter in getting their product onto the US market to get to first revenue.
I suspect the instos are all looking forward for a cheap raise sometime in 2026.
CU6 Price at posting:
$2.09 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)